Computers in Drug Design Flashcards

1
Q

spartan software: ______ software program for analyzing _________

A

representative/ small molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

spartan software analyzes

A

atomic charges, thermodynamics, electrical, solvation and other properties

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

a molecular dynamics program measures ___________

A

the movement of each atom in a structure every femtosecond

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

define femtosecond

A

(1X10^-15)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

molecular dynamics predicts the ___ of each atom at ______

A

energy/ each simulated orientation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

molecular dynamics allows for ____ a molecule to _____________ to ______ and ______

A

“heating”/ introduce energy/ overcome “saddles”/ find lower energy conformation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

molecular modeling describes and predicts how a compound interacts ______ and _______

A

in solution/ with its cellular target(s)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

molecular modeling, compound only =

A

structural overlays

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

molecular modeling, compound and protein target =

A

molecular docking (SBDD), de novo modeling and homology modeling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

True or False: molecular modeling software generates numerous potential structural overlays

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

True or False: molecular modeling software identifies the most likely correct overlay

A

false

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

molecular modeling structural overlays are most often used to

A

1) identify pharmacophore for a series of analogues 2) predict binding conformation of a new series of analogues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

molecular docking:

A

fitting a drug or potential drug into a known binding site and analyzing interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

molecular docking can predict ____ of new compounds before synthesis and evaluation

A

potential binding conformation (and biological activity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

True or False: molecular docking can be manual or automatic

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

molecular docking: rigid target and ligand:

A

simplest and quickest, you need to know the active conformation of ligand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

molecular docking: rigid target/ flexible ligand

A

more complex, you don’t need to know the active conformation of the ligand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

molecular docking: flexible target and ligand

A

very complicated, expensive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the first step in molecular docking?

A

Obtaining the crystal structure - co-crystal structure is important

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

True or false: in molecular docking you identify the amino acids lining the binding site

21
Q

in molecular docking, you identify the key interactions between:

A

ligand-protein and ligand-water molecules

22
Q

in molecular docking, after docking a new compound into the binding site, you identify _________ by _________

A

potential high affinity binders/ binding energy analysis

23
Q

what do you do after you identify a new lead compound through molecular docking?

A

synthesize and test it

24
Q

how do you start de novo modeling?

A

get crystal and co-crystal structure (of ligand in binding site)

25
in de novo modeling, you identify the binding site, the amino acids lining the binding site, other binding regions in the binding site, and then you
design and build new ligands to fit into the binding site
26
you synthesize and test ________
low energy binders
27
what can you use to get a lead compound for SBDD?
de novo modeling
28
homology modeling:
create a three-dimensional model of an unknown protein based on amino acid sequence similarity with a protein of known 3D structure
29
true or false: the majority of different amino acid sequences adopt a relatively small number of structures
true
30
name two secondary structures
alpha helix, beta sheets
31
name two tertiary structures
salt bridges, disulfide bonds
32
___________ is used to predict potential binding sites
homology modeling
33
__________ is used with standard modeling procedures to dock compounds in binding site
homology modeling
34
how do you start homology modeling?
identify homologous proteins and determine sequence similarity
35
after you find homologous proteins for homology modeling and determine sequence similarity, you _____ and identify ______ and _________ regions.
align the sequences/ structurally conserved/ structurally variable
36
in homology modeling, you generate _____ for structurally conserved residues of the unknown structure and _________ for the structurally variable regions in the unknown structure
coordinates/ conformations
37
after you build the side-chain conformations in homology modeling, you
refine and evaluate the unknown structure
38
why should you not design structures that completely fill the binding pocket?
space for future optimization is needed, space allows for different binding conformations than predicted
39
are rigid or flexible newly designed ligands preferred for molecular modeling/ docking?
flexible - allows for different binding conformations
40
when do you add rigidity to ligands?
second or third iterations
41
should the binding conformation of a ligand be a stable conformation?
yes
42
define "in silico"
performed on a computer or via computer simulation
43
docking based screening
virtual libraries are docked into a known receptor or enzyme binding site and scored for their potential ability to bind with high affinity
44
ligand-based screening types:
pharmacophore models and chemical similarity
45
ligand-based screening - pharmacophore models:
compounds known to bind in the same site on a receptor or enzyme are used to build a model of the binding site
46
what is a ligand-based screening pharmacophore model used for?
docking-based screening
47
ligand-based screening - chemical similarity:
lead compound is compared to structure databases to identify other molecular structures with similar pharmacophoric and physicochemical elements
48
are computers utilized at all stages of drug development?
yes